Abstract | OBJECTIVE: To alert clinicians about the risk of vasculitis and cross-reactivity of antithyroid medication. METHODS: We describe the clinical course and medical management of the study patient. RESULTS: CONCLUSIONS:
|
Authors | Khulood Ahmed, Sneha Rao, Vinaya Simha |
Journal | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
(Endocr Pract)
2010 May-Jun
Vol. 16
Issue 3
Pg. 449-51
ISSN: 1934-2403 [Electronic] United States |
PMID | 20061292
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antibodies, Antineutrophil Cytoplasmic
- Antithyroid Agents
- Methimazole
- Propylthiouracil
|
Topics |
- Adult
- Antibodies, Antineutrophil Cytoplasmic
(metabolism)
- Antithyroid Agents
(adverse effects, therapeutic use)
- Drug Interactions
- Female
- Graves Disease
(complications, metabolism)
- Humans
- Methimazole
(adverse effects, therapeutic use)
- Propylthiouracil
(adverse effects, therapeutic use)
- Vasculitis
(drug therapy, metabolism)
|